Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma

ClinicalTrials.gov ID: NCT00865969

Public ClinicalTrials.gov record NCT00865969. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 9:46 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Open-Label Trial of Belinostat in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to assess efficacy and safety of belinostat in participants with relapsed or refractory peripheral T-cell lymphoma (PTCL), who failed at least one prior systemic therapy.

Study identification

NCT ID
NCT00865969
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Spectrum Pharmaceuticals, Inc
Industry
Enrollment
129 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 15, 2008 (Actual)
Primary completion
Nov 5, 2013 (Actual)
Completion
Oct 27, 2014 (Actual)
Last update posted
Oct 29, 2021

2008 – 2014

United States locations

U.S. sites
42
U.S. states
19
U.S. cities
36
Facility City State ZIP Site status
City of Hope National Medical Center Duarte California 91010 —
Wilshire Oncology Medical Group, Inc La Verne California 91750 —
Comprehensive Cancer Center Palm Springs California 92262 —
Yale Cancer Center-Section of Medical Oncology New Haven Connecticut 06520 —
Oncology Associates of Bridgeport Trumbull Connecticut 06611 —
Boca Raton Clinical Research Associates Boca Raton Florida 33432 —
Georgia Health Sciences University Augusta Georgia 30912-3125 —
Northwestern University Chicago Illinois 60611 —
Rush University Medical Center Chicago Illinois 60612 —
Kellogg Cancer Care Center Evanston Illinois 60201 —
Illinois Cancer Specialists/Cancer Care & Hematology Specialists of Chicagoland Niles Illinois 60714 —
Illinois CancerCare, P.C. Peoria Illinois 61615 —
Center for Cancers and Blood Disorders Bethesda Maryland 20817 —
Dana Farber Cancer Institute Boston Massachusetts 02115 —
Boston University Medical Center Boston Massachusetts 02118 —
Karmanos Cancer Institute Detroit Michigan 48201 —
Henry Ford Health System Detroit Michigan 48202 —
Saint Louis University St Louis Missouri 63110 —
Washington University School of Medicine St Louis Missouri 63110 —
Northern New Jersey Cancer Associates Hackensack New Jersey 07601 —
Morristown Memorial Hospital Morristown New Jersey 07962 —
Erie County Medical Center (Roswell Park) Buffalo New York 14215 —
Monter Cancer Center Lake Success New York 11067 —
New York University Cancer Institute New York New York 10016 —
New York University New York New York 10016 —
Memorial Sloan-Kettering Cancer Center New York New York 10021 —
Upstate Medical Univeristy Syracuse Syracuse New York 13210 —
Bronx River Medical Associates, PC The Bronx New York 10467 —
Duke University Medical Center Durham North Carolina 27710 —
Hematology Associates Bedford Ohio 44146 —
St Luke's Cancer Center Bethlehem Pennsylvania 18015 —
Penn State Hershey Cancer Institute Hershey Pennsylvania 17033 —
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 —
Avera Cancer Center Sioux Falls South Dakota 57105 —
Associates In Oncology and Hematology Chattanooga Tennessee 37421 —
University of Tennessee Cancer Institute Knoxville Tennessee 37920 —
Accelerated Community Oncology Reseaerch Network, Inc. (ACORN) Memphis Tennessee 38138 —
UT - M. D. Anderson Cancer Center Houston Texas 77030 —
The UT Health Science Centre at San Antonio San Antonio Texas 78229 —
Massey Cancer Center Richmond Virginia 23298-0035 —
Cascade Cancer Center Kirkland Washington 98304 —
Fred Hutchinson Cancer Research Center - Seattle Cancer Care Alliance Seattle Washington 98109 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 75 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00865969, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 29, 2021 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00865969 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →